Tratamento
Tesamorelin is approved for a narrow clinical group. Here is who was studied, what the trials measured, and where the evidence stops.
Peptides for jiu-jitsu athletes: what the evidence shows, how tournament rules apply, and why diagnosis comes before any decision.
Tirzepatide and semaglutide are both weekly injections for weight loss, but they act on different hormone receptors. Here's what the research and the prescribing information say about the differences.
Generic, similar, and compounded are not the same thing in Brazil. Here is how to read the registration, the bula, and the price before you buy generic semaglutide.
GHK-Cu and collagen peptides both show up on skincare and supplement labels. Here's how to tell them apart and judge the evidence behind each claim.
Does Ozempic protect the kidneys? Here is what the FLOW trial measured in semaglutide users with type 2 diabetes and CKD, what it doesn't show, and what to ask your clinician.
How oral semaglutide gets past the stomach, what changes when you switch from an injection, and which questions to bring to your prescriber before changing anything.
The brand on a social media ad is rarely the company that fills the vial. Here's how the Brazilian semaglutide supply chain works, and what questions can help you trace it.
Serums, shampoos, and clinic menus are full of peptides promised for hair. Here's how to read those claims before you spend money.
Peptide therapy keeps appearing in health discussions, but understanding when it genuinely fits a weight loss strategy requires separating mechanism from marketing. Here's what the evidence actually shows.
Most peptide molecules are too large to penetrate skin effectively. Here's what research shows about adhesive peptide delivery, bioavailability, and where the evidence stands today.
Cost barriers push Brazilian patients toward informal semaglutide sources. Here's what you need to know about risks, regulation gaps, and safer alternatives.